Northern Trust’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1K | Hold |
25,763
| – | – | ﹤0.01% | 4282 |
|
|
2025
Q1 | $45.6K | Hold |
25,763
| – | – | ﹤0.01% | 4242 |
|
|
2024
Q4 | $59.3K | Hold |
25,763
| – | – | ﹤0.01% | 4243 |
|
|
2024
Q3 | $91.2K | Hold |
25,763
| – | – | ﹤0.01% | 4080 |
|
|
2024
Q2 | $71.4K | Buy |
+25,763
| New | +$71.4K | ﹤0.01% | 4128 |
|
|
2022
Q4 | – | Sell |
-5,690
| Closed | -$24K | – | 4718 |
|
|
2022
Q3 | $24K | Hold |
5,690
| – | – | ﹤0.01% | 4516 |
|
|
2022
Q2 | $30K | Sell |
5,690
-704
| -11% | -$3.71K | ﹤0.01% | 4557 |
|
|
2022
Q1 | $65K | Hold |
6,394
| – | – | ﹤0.01% | 4473 |
|
|
2021
Q4 | $72K | Hold |
6,394
| – | – | ﹤0.01% | 4517 |
|
|
2021
Q3 | $130K | Hold |
6,394
| – | – | ﹤0.01% | 4333 |
|
|
2021
Q2 | $160K | Hold |
6,394
| – | – | ﹤0.01% | 4230 |
|
|
2021
Q1 | $183K | Buy |
6,394
+5,056
| +378% | +$145K | ﹤0.01% | 4140 |
|
|
2020
Q4 | $28K | Hold |
1,338
| – | – | ﹤0.01% | 4298 |
|
|
2020
Q3 | $35K | Buy |
+1,338
| New | +$35K | ﹤0.01% | 4145 |
|
|
2018
Q2 | – | Sell |
-906
| Closed | -$147K | – | 4337 |
|
|
2018
Q1 | $147K | Buy |
906
+22
| +2% | +$3.57K | ﹤0.01% | 3886 |
|
|
2017
Q4 | $186K | Sell |
884
-67
| -7% | -$14.1K | ﹤0.01% | 3837 |
|
|
2017
Q3 | $254K | Buy |
+951
| New | +$254K | ﹤0.01% | 3723 |
|